Pooled Procurement Of Cancer Drugs In India: Is Pharma Game For More?

India’s National Cancer Grid pilots pooled procurement for 40 drugs including trastuzumab, imatinib, and pemetrexed, delivering median savings of over 80%. Experts discuss with Scrip the prospects of scaling the initiative and what it may mean for pharma’s margins and go-to-market strategy.

India's National Cancer Grid Pilots Pooled Procurement Of Drugs • Source: Shutterstock

A pilot pooled procurement initiative for 40 drugs by the National Cancer Grid (NCG) has helped shrink cancer care costs significantly in India, pointing to the impact of group negotiation for high-value treatments and signalling what may be in store for pharma if the initiative is successfully scaled or applied more widely across therapy areas.

Key Takeaways

  • India’s National Cancer Grid pilots pooled procurement for 40 drugs

The NCG’s initiative saw savings of INR13.2bn ($166.7m) compared to the maximum retail prices (MRP) of the drugs covered which...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet